Daiichi Sankyo news · coda.news

About

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.

Source: Wikipedia (CC BY-SA)

On coda.news

1 event, reported by media in 1 country

Latest news

economy2 d ago

IHH Healthcare's unit appeals a court dismissal of its damages claim against Daiichi Sankyo.

According to CNA Business, IHH Healthcare's subsidiary in Malaysia appealed a Tokyo court's dismissal of its damages claim against Daiichi Sankyo over Fortis Healthcare stake acquisition. The court had on Sept. 10 dismissed NTK's claims and ruled IHH's unit must cover litigation costs; NTK had sought up to 109.3 billion Indian rupees (about $1.14 billion).

Similar companies

Takeda Pharmaceutical

IHH Healthcare's unit appeals a court dismissal of its damages claim against Daiichi Sankyo.

economy2 d ago

coda.news AI summary

NTK petitioned in May 2025 to seek damages up to 109.3 billion Indian rupees.
The Tokyo court dismissed the NTK claims and said IHH's unit must bear litigation costs on Sept. 10.
IHH's subsidiary appealed the dismissal on Sept. 24.
NTK concluded the case warrants appellate review and exercised its right of appeal.
Fortis and Daiichi Sankyo did not immediately respond to Reuters requests for comment.

IHH Healthcare Daiichi Sankyo Fortis Healthcare

CNA BusinessRead original ↗

Takeda Pharmaceutical

Japan

›

Japan Airlines